Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer.

		Keywords:		Stem cell transplant

		Phase:		Phase 2

		Treatment ID#s:		VT350

		Age Group:		Adult And Pediatric

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		11/27/2005

		Tumor Types:		Anaplastic Astrocytoma Brainstem Glioma Ependyoma Germ Cell Tumors Glioblastoma Multiforme Gliosarcoma Hemangioblastoma Lymphomas Medulloblastoma Metastatic Brain Tumor Oligodendroglioma High Grade PNET Tumor


		Comments:		No prior treatment with Thiotepa in previous 9 months.

		Treatment Type:		Chemotherapy.

		Contact:		Childrens Hospital Los Angeles Jonathan Finlay Contact: Dr. Jonathan Finley 4650 Sunset Blvd., Mail Stop #54 Los Angeles, CA 90027 Phone:(323) 906-8147 Fax: 323 906-8165 Click here to send an email Website: www.childrenshospitalla.org/

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By